Prior Authorization Workflow: From Prescription to Payor Decision

The prior authorization workflow can be improved through efficiency in conducting the process of determining a patient’s eligibility, proper documentation, proper submission of information, continuous monitoring of status, and follow-up.

Prescribing is fast. Payor decisions are not. And that gap, the space between “the provider ordered it” and “the plan approved it”, is where delays, rework, and patient frustration tend to pile up.

The good news is that PA isn’t random. When you map it out, the process is actually predictable. The challenge is that many teams don’t have a consistent way to run it, so requests get stuck in “pending,” documentation goes missing, and everyone ends up doing extra follow-ups.

That’s why the prior authorization workflow matters.

Prior authorization workflow affects the time taken to initiate treatment after issuing the prescription. It also assists in minimizing unnecessary delays caused by inefficiency in the prior authorization process through filing clean prior authorization requests and timely responses to the payor’s questions.

In this blog, we’ll break down the prior auth workflow from prescription to payor decision, step by step, so every request stays owned, tracked, and moving.

Quick Definitions

What Is Prior Authorization?

Prior authorization is insurer approval required before certain medications, treatments, or services are covered.

What Is the Prescription Prior Authorization Process Specifically?

It is prior authorization related to a specific drug and is usually caused by such reasons as formulary constraints, step therapy, quantity limit, and/or specialty drugs.

Difference Between Rejected, Denied, and Pending (one-liner each):

• Rejected: Cannot be processed because of incomplete submission, incorrect form, administrative issue.
• Pending: Received but pending for further review/information.
• Denied: Reviewed but did not fit the criteria.

The Stakeholders:

The prescriber’s office, payor/PBM, pharmacy, and the patient; and the process works as good as the coordination among all the parties.

Prior Authorization Steps: From Prescription to Payor Decision (Process Map)

Step 1: Identify PA Requirement Early (Before the Prescription Stalls)

PA requirements can show up at the point of care or later at the pharmacy when the claim rejects.

Common triggers:

• Formulary restrictions
• Step therapy requirements
• Quantity limits
• Specialty medication rules

Best practice: Check PA requirements early at the point of care (or during scheduling/pre-visit planning) to prevent last-minute delays.

Step 2: Verify Benefits, Eligibility, and Payor Pathway

Before you gather documentation, confirm the basics:

• Active coverage and plan details
• Correct benefit pathway (medical vs pharmacy benefit)
• Correct submission channel (payor portal, ePA, PBM-specific process)

This step prevents “wrong-path” submissions, which are a quiet but common cause of rejections.

Step 3: Gather the Right Clinical Documentation (Make It “First-Pass Ready”)

This is where most delays start, because missing documents often trigger pends and resubmissions.

Common documentation includes:

• Diagnosis and severity (ICD-10)
• Chart notes and medical necessity rationale
• Labs or imaging results (if required)
• Prior therapies tried/failed and contraindications
• Attachments aligned to payor criteria

Best practice: Employ payor-specific checklists so that you will know exactly what “complete” means.

Step 4: Submit the PA Request (Clean, Complete, and Payor-Specific)

Submissions must be of the highest quality foremost. Clean submissions lead to less pends.

Remember to:

• Use the right submission form and payor requirements
• Verify patient demographic and insurance information
• Verify codes (ICD-10/CPT/NDC as appropriate)
• Submit via electronic transmission to avoid missed fields and to expedite processing

There are tools available for this that remind you of required fields and help to avoid mistakes like “Oops, forgot the attachment!” (You’ll sometimes hear about RxEPA being used in the ePA world, but the real benefit is submission plus submission status.)

Step 5: Track Status and Respond Quickly to Payor Requests

Submitting is not the finish line. Tracking is what prevents requests from stalling.

Monitor the request through:

Submitted → pending → needs info → approved/denied

Best practices:

• Respond quickly to pends and additional documentation requests
• Use internal SLAs and reminders (example: status check every 48 hours)
• Assign one clear owner per request so it doesn’t fall into a handoff gap

Step 6: Payor Decision and Next Steps (Approval, Denial, or Appeal)

Once the payor decides, the workflow branches.

If approved:

• Communicate approval to the pharmacy and patient
• Confirm the next step for dispensing or therapy start
• Document approval details for future reference

If denied: Use a Simple Decision Tree

• Fix and resubmit (missing info or admin issue)
• Move to an alternative that is covered (where applicable)
• Appeal or peer-to-peer review (medical necessity issue)

Best practice: Record the outcome and reasons for denial in order to make improvements in the future.

The prior authorization steps will ensure that the prescription prior authorization is consistent throughout the process.

Where Does the Prior Authorization Process Break Down Most Often?

Most breakdowns are predictable, which is good news, because predictable problems can be prevented.

Common breakdown points:

• Missing documentation
• Wrong or outdated forms
• Incorrect coding (ICD-10/CPT/NDC mismatch)
• Late submission
• No ownership or follow-up cadence
• Payor criteria not met (step therapy, quantity limits)

If your team is constantly “starting over,” it’s usually one of these.

Best Practices to Streamline the Prior Auth Workflow (Practical Playbook)

If you want fewer delays without adding staff, focus on workflow discipline:

• Begin early: incorporate PA validation in prescriptions and schedules
• Use payor-specific checklists and templates
• Establish responsibility and SLAs for follow-up
• Employ electronic submission and status tracking whenever possible
• Identify the leading causes of denials and fix the top three each month

Small improvements add up quickly when there are many PAs.

Metrics to Track (Prove Your Workflow Is Improving)

To improve the process, you need visibility. Track:

• Time to submit (prescription → submission)
• Time to decision (submission → payor decision)
• First-pass approval rate
• Pend rate and reasons
• Denial rate and top denial reasons
• Appeal volume and overturn rate
• Patient abandonment rate (if applicable)

These metrics show whether your workflow is getting cleaner, faster, and more predictable.

FAQs

1) How Long Does the Prescription Prior Authorization Process Take?

It depends on the payor, the drug, and the level of submission completeness. There are usually many cases of delays due to missing documentation and slow response to payor requests for additional information.

2) What Documents Speed Up Prior Authorization Approvals?

Chart notes proving medical necessity, relevant labs and imaging (if required), severity of the disease and the prior treatment experience (with results) are usually the most effective documents.

3) What Happens if a Prior Authorization Is Denied?

It is important to distinguish whether it is an easily solvable problem or a true denial. Then one needs to pick up the appropriate course of action.

Conclusion: Faster Payor Decisions Come From Cleaner Submissions + Consistent Tracking

No magic happens here; it is all about quality inputs and consistent action.

An efficient prior authorization workflow starts with streamlined documentation and follow-through. Better results from the prior authorization process are achieved through consistent documentation and follow-up. An efficient prior auth process will keep the request in motion from the prescription to the payor decision.

Standardization of the prior authorization steps will increase the number of initial authorizations and make the entire prescription prior authorization process much more predictable.